Central involvement of kinin B1 and B2 receptors in the febrile response induced by endotoxin in rats
- 1 May 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 121 (2) , 296-302
- https://doi.org/10.1038/sj.bjp.0701110
Abstract
1. The effect of central injection of selective kinin B1 and B2 receptor antagonists on the febrile response induced by endotoxin (E. coli lipopolysaccharide, LPS) in rats was investigated. 2. Intracerebroventricular (i.c.v.) injection of a selective B2 receptor antagonist (Hoe-140, 8 nmol) reduced the early (0-2 h), but increased the late phase (4-6 h) of the febrile response induced by intravenous (i.v.) injection of LPS (0.5 microgram kg-1). 3. Co-administration of Hoe-140 (8 nmol, i.c.v.) with LPS (0.5 microgram kg-1, i.v.), followed 2.5 h later by the i.c.v. injection of a selective B1 receptor antagonist [des-Arg9-Leu8]-bradykinin (BK, 8 nmol), significantly reduced the febrile response induced by LPS throughout the whole experimental period. 4. Intravenous injection of Hoe-140 (1 mg kg-1) significantly reduced the febrile response induced by LPS (0.5 microgram kg-1, i.p.). 5. Pretreatment (24 h) with LPS (0.5 microgram kg-1, i.v.) reduced the febrile response induced by BK or [Tyr8]-BK (both, 5 nmol, i.c.v.), but markedly increased the febrile response induced by [des-Arg9]-BK (5 nmol, i.c.v.). The response induced by [des-Arg9]-BK in LPS-pretreated rats was significantly inhibited by co-injection of [des-Arg9-Leu8]-BK (15 nmol, i.c.v.). 6. The results suggest that kinins are involved in the induction of LPS-induced fever and that central B2 and B1 receptors are activated during the initial and late phase of this response, respectively. The results also suggest that downregulation and/or desensitization of B2 receptors and induction and/or upregulation of B1 receptors in LPS-pretreated animals may have a significant pathophysiological role in the induction and maintenance of fever. These observations may be specifically important in the case of chronic inflammatory conditions, because the BK metabolite [des-Arg9]-BK, so far considered an inactive metabolite, acquires an active and relevant role with the progressive expression of B1 receptors that occurs in such states.Keywords
This publication has 44 references indexed in Scilit:
- Upregulation of B1 receptor mediating des‐Arg9‐BK‐induced rat paw oedema by systemic treatment with bacterial endotoxinBritish Journal of Pharmacology, 1996
- Expression of B1 kinin receptors mediating paw edema and Formalin-induced nociception. Modulation by glucocorticoidsCanadian Journal of Physiology and Pharmacology, 1995
- Involvement of B1 and B2 receptors in bradykinin‐induced rat paw oedemaBritish Journal of Pharmacology, 1995
- Evidence for participation of B1 and B2 kinin receptors in formalin‐induced nociceptive response in the mouseBritish Journal of Pharmacology, 1993
- Opioid mediation of the antiaversive and hyperalgesic actions of bradykinin injected into the dorsal periaqueductal gray of the ratPhysiology & Behavior, 1992
- Kallidin and bradykinin metabolism by isolated cerebral microvesselsBiochemical Pharmacology, 1988
- Bradykinin-like immunoreactive neuronal systems localized histochemically in rat brain.Proceedings of the National Academy of Sciences, 1979
- Changes in rectal temperature of the rabbit by intracerebroventricular injection of bradykinin and related kininsInflammation Research, 1978
- Central mechanisms of the hypertensive action of intraventricular bradykinin in the unanaesthetized ratNeuropharmacology, 1974
- Catatonia induced in the rabbit by intracerebral injection of bradykinin and morphineEuropean Journal of Pharmacology, 1971